A retrospective study of ensartinib-treated ALK -positive locally advanced or metastatic NSCLC patients in China.

Xiaobin YuanYang WangMin YangPengxiang WuHui ChenYu YunZhilin ShenDong JiYongbin MaLieming Ding

Published in: Lung cancer management (2023)

-positive NSCLC patients in real-world clinical settings.

Keyphrases